This talk is from a 2009 user group meeting in Budapest, where I spoke about an implementation at Wyeth in the Bioanalytical / Biotransformation area that I was responsible for.
My role was Strategy & Operations, Business Systems & Processes for Discovery, Preclinical Development & Vaccines, as well as Senior Account Manager, Drug Safety & Metabolism.
As a part of this role, I inherited a legacy of challenges which needed to be addressed as a part of this program and overall solution success. In the talk, I outline some of the challenges, my responses and also how the implementation was drive.
You will see my early thinking on the program structure, which I re-used at Pfizer and beyond, having recognized the value the “ecosystem” view provides.
The slides are available here, and as always I welcome your conversation and engagement.